layerdegree0
About
Telomerase-based GX301 cancers vaccine within patients together with metastatic castration-resistant prostate type of cancer: a new randomized stage 2 test.
Telomerase-based GX301 cancers vaccine within patients together with metastatic castration-resistant prostate type of cancer: a new randomized stage 2 test.